SPEND ENOUGH TIME in the gym (or consume enough fitness-related content online), and you’re sure to encounter plenty of physiology terms. If you’re not a trainer yourself or you never took any type of ...
Flexion Therapeutics, Inc. FLXN will provide updates on revenues from Zilretta and its other pipeline developments when it reports third-quarter 2021 results. The company’s earnings history has been ...
Flexion Therapeutics (FLXN) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates - ...
After announcing that it would be raising capital in the form of convertible bond offering, shares of Flexion Therapeutics (NASDAQ: FLXN) have fallen 15% as of 11:15 a.m. EDT. Flexion stated that it ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Flexion Therapeutics, Inc. (NASDAQ: FLXN) to Pacira BioSciences, Inc. for $8.50 per ...
Tampa, Fla.-based Pacira BioSciences Inc. said Monday it is acquiring Flexion Therapeutics Inc. , based in Burlington, Mass., for $8 a share in cash, plus a non-tradeable contingent value right (CVR) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback